Study of structural and mechanical properties of suppositories with bifonazole

Authors

DOI:

https://doi.org/10.14739/2409-2932.2025.1.311910

Keywords:

bifonazole, gynecology, dosage forms, pharmacotherapy, suppositorie, process temperature, thixotropy, stability

Abstract

Currently, candidal vulvovaginitis is one of the most common infectious lesions of the mucous membrane of the vulva and vagina. The prevalence of this infection is one of the main reasons for impaired reproductive function and the development of pregnancy complications. In addition, this pathology is an important medical and social problem both for the healthcare system and for society, as it significantly reduces the quality of life of patients due to the manifestation of characteristic adverse symptoms. Treatment of candidal vulvovaginitis should be not only etiotropic, considering the species of the causative agent, but also pathogenetic. In addition, this pathology is an important medical and social problem both for the healthcare system and for society. As it significantly reduces the quality of life of patients due to the manifestation of characteristic adverse symptoms. Treatment of candidal vulvovaginitis should be not only etiotropic, considering the species of the causative agent, but also pathogenetic. One of the promising biologically active substances is bifonazole, which is an antifungal compound of the azole group with a wide spectrum of action. Based on complex physico-chemical, microbiological and biopharmaceutical research, the Department of Medicines Technology of the Zaporizhzhia State Medical and Pharmaceutical University developed a rational composition of the soft vaginal dosage form of bifonazole – suppositories containing 0.3 g of the active substance on a hydrophobic carrier.

The aim of this work is to study the rheological characteristics of the vaginal dosage form of bifonazole, depending on the temperature regime of the production process for the suppositories manufacture.

Materials and methods. The study of the structural and mechanical characteristics of the suppository mass with bifonazole based on cocoa oil with the addition of 5 % emulsifier No. 1 was carried out using a rotary viscometer “Reotest-2” with a cylindrical device at a human body temperature of +37 °С and the temperature of the technological process of manufacturing the dosage form.

Results. They indicate the existence of a present structure in the suppository composition, that is evidenced by the decrease in effective viscosity simultaneously with the increase in deformation forces. The obtained data enable us to analyze the strength characteristics of the suppository mass and to calculate the main parameters of structural and mechanical studies, which allow us to conduct an objective assessment of the consistency studies of the system.

Conclusions. The consistent properties of the suppository mass with bifonazole based on cocoa oil with the addition of 5 % emulsifier No. 1 at human body temperature were studied. It was established, that it is a structured system with pronounced thixotropic properties, in which there is a uniform distribution of biologically active and auxiliary substances both at the time of manufacture and during use and long-term storage. It was found, that increasing the temperature of the suppository mass to +50 °С does not lead to a significant change in its structural and mechanical properties and transformation into a Newtonian system. Considering the obtained data, it was established, that the temperature regime for the manufacture of vaginal suppositories with bifonazole on a lipophilic basis (mixing, homogenization, pouring into molds) in the range of +50–55 °С creates sufficient fluidity of the mass for the unhindered implementation of the technological process and thixotropy of the suppositories, distribution of active and auxiliary substances in this dosage form.

Author Biographies

T. V. Mielnyk, Zaporizhzhia State Medical and Pharmaceutical University

PhD-student of the Department of Medicines Technology

H. P. Lysianska, Zaporizhzhia State Medical and Pharmaceutical University

PhD, Associate Professor of Department of Medicines Technology

References

Jafarzadeh L, Ranjbar M, Nazari T, Naeimi Eshkaleti M, Aghaei Gharehbolagh S, Sobel JD, et al. Vulvovaginal candidiasis: An overview of mycological, clinical, and immunological aspects. J Obstet Gynaecol Res. 2022;48(7):1546-60. doi: https://doi.org/10.1111/jog.15267

Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18(11):e339-e347. doi: https://doi.org/10.1016/S1473-3099(18)30103-8

Mtibaa L, Fakhfakh N, Kallel A, Belhadj S, Salah NB, Bada N, et al. Vulvovaginal candidiasis: Etiology, symptomatology and risk factors. J Mycol Med. 2017;7(2):153-8. doi: https://doi.org/10.1016/j.mycmed.2017.01.003

Phillips NA, Bachmann G, Haefner H, Martens M, Stockdale C. Topical treatment of recurrent vulvovaginal candidiasis: an expert consensus. Womens Health Rep (New Rochelle). 2022;3(1):38-42. doi: https://doi.org/10.1089/whr.2021.0065

Satora M, Grunwald A, Zaremba B, Frankowska K, Żak K, Tarkowski R, et al. Treatment of Vulvovaginal Candidiasis-An Overview of Guidelines and the Latest Treatment Methods. J Clin Med. 2023;12(16):5376. doi: https://doi.org/10.3390/jcm12165376

Mustapha AD, Oyedepo FM, Akin-Ajani OD, Odeku OA. Design and evaluation of antifungal vaginal suppository using coconut oil as base for vulvovaginal candidiasis. Futur J Pharm Sci. 2023;9(1):80-91. doi: https://doi.org/10.1186/s43094-023-00533-w

Pashayan MM, Hovhannisyan HG. Development of bifunctional vaginal suppositories by joint use terconazole and probiotic for treatment and prophylaxis of vulvovaginal candidiasis. Drug Dev Ind Pharm. 2021;47(9):1424-31. doi: https://doi.org/10.1080/03639045.2021.2001485

Burdette L. Challenging Vaginas: Case Studies in Recognizing and Treating Vulvovaginitis. Phys Assist Clin. 2018;3(3):411-21. doi: https://doi.org/10.1016/j.cpha.2018.02.009

Liu Y, Li M, Yi H, Song D, Lou Y, Fan S, et al. Efficacy and safety of Fufang Furong Effervescent Suppository for the treatment of mixed vaginitis: a randomized, multicenter, and non-inferiority study. Pharmacological Research - Modern Chinese Medicine. 2023;7:100225. doi: https://doi.org/10.1016/j.prmcm.2023.100225

Krishna AV, Gowda VD, Karki R. Formulation and evaluation of nanosponges loaded Bifonazole for fungal infection. Antiinfect Agents. 2021;19(1):64-75. doi: https://doi.org/10.2174/2211352518999200711164437

Mielnyk TV, Kolycheva NL. [Study of the effect of bifonazole concentration on the antifungal activity of vaginal suppositories]. Current issues in pharmacy and medicine: science and practice. 2024;17(1):48-51. Ukrainian. doi: https://doi.org/10.14739/2409-2932.2024.1.294647

Melnik GM, Yarnykh TG, Herasymova IV. [Determination of the main technological parameters of the manufacture of pessaries (vaginal suppositories) for preparation of the birth canal before childbirth]. Medychna ta klinichna khimiia. 2021;23(2):70-6. Ukrainian. doi: https://doi.org/10.11603/mcch.2410-681X.2021.i2.12242

Kuchina LК, Gladyshevа SА, Puchalskaya IA. [The study of structural-mechanical properties of diltiazem suppositories]. Current issues in pharmacy and medicine: science and practice. 2015;(2):41-4. Russian. doi: https://doi.org/10.14739/2409-2932.2015.2.45197

Redkina YА, Gladyshev VV, Burlaka BS. [The study of structural-mechanical characteristics of suppositories with clopidogrel]. Current issues in pharmacy and medicine: science and practice. 2018;11(3):281-5. Russian. doi: https://doi.org/10.14739/2409-2932.2018.3.145218

Oliynyk I, Fedorovska M, Lisianskaia A, Gladysheva S. [Study of structural and mechanical characteristics of suppositories with cranberry oil]. Polish Journal of Science. 2019;21(1):34-8. Ukrainian.

Additional Files

Published

2025-03-10

How to Cite

1.
Mielnyk TV, Lysianska HP. Study of structural and mechanical properties of suppositories with bifonazole. Current issues in pharmacy and medicine: science and practice [Internet]. 2025Mar.10 [cited 2025Apr.17];18(1):64-8. Available from: http://pharmed.zsmu.edu.ua/article/view/311910